This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Novartis Ag. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Lorenzo Sacchetti: Innovator in Radiopharmaceuticals
Introduction
Lorenzo Sacchetti is a notable inventor based in Turin, Italy. He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative patent that addresses the stability and concentration of radionuclide complex solutions. His work is essential for advancing diagnostic and therapeutic applications in medicine.
Latest Patents
Lorenzo Sacchetti holds a patent for a "Stable, concentrated radiopharmaceutical composition." This patent focuses on radionuclide complex solutions that exhibit high concentration and chemical stability. The invention allows these solutions to be used as drug products for both diagnostic and therapeutic purposes. The stability of the drug product is achieved by incorporating at least one stabilizer to prevent radiolytic degradation. Notably, the use of two stabilizers introduced at different stages during the manufacturing process has proven particularly advantageous.
Career Highlights
Lorenzo Sacchetti is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to work on cutting-edge research and development in the field of pharmaceuticals. His expertise in radiopharmaceuticals has positioned him as a key player in the industry.
Collaborations
Lorenzo has collaborated with esteemed colleagues such as Maurizio F Mariani and Lorenza Fugazza. These collaborations have further enriched his research and contributed to the advancement of innovative solutions in the pharmaceutical sector.
Conclusion
Lorenzo Sacchetti's contributions to the field of radiopharmaceuticals highlight his innovative spirit and dedication to improving medical diagnostics and therapies. His patent for stable, concentrated radiopharmaceutical compositions is a testament to his expertise and commitment to advancing healthcare solutions.
